Pharmacokinetics of atenolol in clinically normal cats

American Journal of Veterinary Research

Volumn 57, Issue 7, 1996, Pages 1050-1053

  Quinones M ^a,c   Dyer, D C ^a   Ware, W A ^a   Mehvar, R ^b  

^a IOWA STATE UNIVERSITY   (United States)

^b DRAKE UNIVERSITY   (United States)

^c Veterinary Teaching Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL;

ANIMAL EXPERIMENT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CAT; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PHARMACOKINETICS;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ATENOLOL; CATS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HALF-LIFE; HEART RATE; INJECTIONS, INTRAVENOUS; ISOPROTERENOL; MALE; METABOLIC CLEARANCE RATE; TIME FACTORS;

EID: 0030017977     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kirch W, Görg KG. Clinical pharmacokinetics of atenolol - a review. Eur J Drug Metab Pharmacokinet 1982;7:81-91.
2. Mehvar R. Liquid chromatographic analysis of atenolol enantiomers in human plasma and urine. J Pharm Sci 1989;78:1035-1039.
3. Morgan RV. Systemic hypertension in four cats: ocular and medical findings. J Am Anim Hosp Assoc 1986;22:615-621.
4. Nadelmann J, Frishman W. Clinical use of beta-andrenoceptor blockade in systemic hypertension. Drugs 1990;39:862-876.
5. Andersson KE, Vinge E. Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine. Drugs 1990;39:355-373.
6. Hjalmarson A, Waagstein F. The role of beta-blockers in the treatment of cardiomyopathy and ischemic heart failure. Drugs 1994;47(Suppl 4):31-40.
7. Frishman WH. β-Adrenergic blockers. Med Clin North Am 1988;72:37-81.
8. Muir WW. Clinical pharmacodynamics and pharmacokinetics of beta-adrenoceptor blocking drugs in veterinary medicine. Compend Contin Educ Pract Vet 1989;6:156-167.
9. Ware WA. Current uses and hazards of beta-blockers. In: Kirk's current veterinary therapy XI. Philadelphia: WB Saunders Co, 1992;676-689.
10. Reeves PR, Barfield DR, Longshaw S, et al. Disposition and metabolism of atenolol in animals. Xenobiotica 1978;8:305-311.
11. Gibaldi M, Perrier D. Pharmacokinetics. New York: Marcel Dekker, 1982;409-416.
12. Bennet LZ. Pharmacokinetics: absorption, distribution and elimination: basic & clinical pharmacology. Norwalk, Conn: Appleton & Lange, 1992;35-48.
13. Shumaker RC. PKCAIC: a basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metab Dispos Biol Fate Chem 1986;17:331-348.
14. Wadworth AN, Murdoch D, Brogden RN. Atenolol: a reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs 1991;42:468-510.
15. McAinsh J, Simpson WT, Holmes BF, et al. Bioavailability of atenolol formulations. Biopharm Drug Dispos 1980;1:323-332.
16. Wolf-Coporda A, Plavsic I, Vrhova B. Determination of biological equivalence of two atenolol preparations. Int J Clin Pharmacol Ther Toxicol 1987;25:567-571.
17. Buck ML, Wiest D, Gillette P. Pharmacokinetics and pharmacodynamics of atenolol in children. Clin Pharmacol Ther 1989; 46:629-633.
18. McDevitt DG, Brown HC, Carruthers SG, et al. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta-adrenoceptor blockade. Clin Pharmacol Ther 1976;21:556-566.
19. Amery A, De Plaen JR, Lijnen P, et al. Relationship between the blood level of atenolol and pharmacologic effect. Clin Pharmacol Ther 1977;21:691-699.
20. Brown HC, Carruthers SG, Johnston SG, et al. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther 1976;20:524-534.
21. Broode OE. Beta-adrenoceptor in cardiac disease. Pharmacol Ther 1993;60:405-430.
22. Pringle TH, Riddle JG. The cardioselectivity of beta adrenoceptor antagonist. Pharmcol Ther 1990;45:39-68.
23. Arnold JMO, McDevitt DG. Reflex vagal withdrawal and the hemodynamic response to intravenous isoproterenol in the presence of beta antagonist. Clin Pharmacol 1986;40:199-208.